"My question goes to the FDA forcing RVX's hand, when RVX wanted a ROSUVASTATIN (ahem)-only trial. Is that Rodman conference quote the only source of those rumours? I don't think it goes as far as that."

Jonzobot, perhaps you haven't been following RVX as closely or as long as some of us here......but my memory clearly tells me that the early planning stages of BETonMACE were to have a rosuvastatin only trial and that this was communicated in some way or another to shareholders. However, the trial design was still in flux at that point in time. The Rodman conference was just before the BETonMACE trial started....so the trial design was finalized at that point to include both statins. There is probably something out there in the interwebz in the mid-2013 to mid-2015 range that supports what I describe above. I really don't care to dig anything up and prove it to you. If it means that much to you to get clarity on this then contact management. Maybe others on this board can provide a another source for you.

BDAZ